Atlas Trials

Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus

Clinical trial NCT01389895 · TERMINATED

Trial details

NCT number
NCT01389895
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cutaneous LupusLupus
Start date
2011-10-01
Primary completion
2013-03-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.